Indolent b cell lymphoma

LymphomaOctober 15, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Indolent B-cell lymphomas are a group of slow-growing subtypes of non-Hodgkin lymphoma that affect B lymphocytes (a type of white blood cell).

Some key points about indolent B-cell lymphomas from authoritative sources:

  • According to the National Comprehensive Cancer Network (NCCN) Guidelines, common indolent B-cell lymphoma subtypes include follicular lymphoma, marginal zone lymphomas, small lymphocytic lymphoma/chronic lymphocytic leukemia, and lymphoplasmacytic lymphoma.

  • These lymphomas are considered indolent or low-grade because the cancer cells tend to grow and spread slowly compared to aggressive lymphomas.

  • Indolent lymphomas are often incurable with standard treatments, but they generally respond well initially to treatment aimed at controlling the disease long-term (ASCO Patient Guide).

  • Common symptoms can include enlarged lymph nodes, fatigue, night sweats, and weight loss. However, some patients have no obvious symptoms early on.

  • Treatment depends on the specific subtype but can involve watchful waiting, chemotherapy, targeted drugs, radiation therapy, or stem cell transplantation in some cases (NCCN Guidelines).

  • These lymphomas have plateaus where the disease is stable, even without treatment, which is why watchful waiting is an approach used when patients have minimal symptoms.

Let me know if you need any clarification or have additional questions! I'm happy to provide more details from reliable medical sources.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: